TEVA PHARMACEUTICAL INDUSTRIES LTD·4

Mar 2, 7:37 AM ET

Shani Eli 4

4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Mar 2, 2023

Insider Transaction Report

Form 4
Period: 2023-02-28
Shani Eli
EVP,Global Marketing&Portfolio
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2023-02-28+5,31125,052 total
  • Exercise/Conversion

    Restricted Share Units

    2023-02-285,3115,312 total
    Ordinary Shares (5,311 underlying)
Footnotes (3)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F3]Restricted share units were granted on February 28, 2020 with 5,311 vested on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 5,312 vesting on February 28, 2024.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION